Dr Robert Levy, Editor-in-Chief of Neuromodulation: Technology at the Neural Interface, and an Executive Board Member of the International Neuromodulation Society (INS), briefly discusses the scientific program for the INS 2017 13th World Congress. The meeting takes place 27 May – 1 June 2017 in Edinburgh, Scotland.
Source: This video was produced by the INS (http://www.neuromodulation.com/ins-congress) and is shared here with permission.
Share this Video
Related Videos In Epilepsy
Mary Koenig, AES 2021: Ganaxolone for the Treatment of Tuberous Sclerosis Complex
touchNEUROLOGY met with Professor Mary Koenig (McGovern Medical School, UTHealth, Houston, TX, USA) to discuss the efficacy and safety findings from the phase 2 Violet study, investigating oral ganaxalone in PCDH19-Clustering Epilepsy (NCT03865732). The abstract ‘Phase 2 Open-label Clinical Study Evaluating Oral Ganaxolone for the Treatment of Seizures Associated with Tuberous Sclerosis Complex‘ (Abstract number: […]
Monica Ferrer Socorro & Jacqueline French, AES 2021: Delayed Diagnosis in Childhood- vs. Adult-Onset Focal Epilepsy
It was a great pleasure to meet with both Dr Monica Ferrer Socorro (NYU Langone Health, New York City, NY, USA) and Prof. Jacqueline French (NYU Grossman School of Medicine, New York City, NY, USA) to discuss a retrospective analysis investigating focal epilepsy, its clinical presentation in adolescents, highlighting disproportionate delay to diagnosis experienced by […]
Michael Sperling AES, 2021: Diazepam Nasal Spray in Patients with Seizure Clusters – Subgroup Analysis from a Phase 3 Safety Study
touchNEUROLOGY met with Prof. Michael Sperling (Thomas Jefferson University, Philadelphia, PA, USA) to discuss a subgroup analysis from a phase 3 safety study investigating the use of diazepam nasal spray in patients with seizure clusters concomitantly receiving clobazam. Diazepam nasal spray is an FDA-approved nasal spray version of diazepam, indicated for the treatment of acute, […]
Journal articles and more to your inbox
Get the latest clinical insights from touchNEUROLOGYSign me up!